1. |
KimV, Rogers TJ, Criner GJ. New concepts in the pathobiology of chronic obstructive pulmonary disease. Proc AmThorac Soc, 2008, 5:478-485.
|
2. |
Macdougall IC, Cooper AC. Hyporesponsiveness to erythropoietic therapy due to chronic inflammation. Eur J Clin Invest, 2005, 35( Suppl 3) : S32-S35.
|
3. |
Hanriot D, Bello G, Ropars A, et al. C-reactive protein induces proand anti- inflammatory effects, inducing activation of the liver X receptor alpha, on human monocytes. Thromb Haemost, 2008 , 99 :558-569.
|
4. |
Karadag F, Kirdar S, Karul AB, et al. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur J Intern Med, 2008, 19: 104-108.
|
5. |
van der Putten K, Braam B, Jie KE, et al. Mechanisms of Disease:erythropoietin resistance in patients with both heart and kidney failure. Nat Clin Pract Nephrol, 2008 , 4: 47 -57.
|
6. |
Means RT Jr. Advances in the anemia of chronic disease. Int J Hematol, 1999, 70: 7-12.
|
7. |
Jacober ML, Mamoni RL, Lima CS, et al. Anaemia in patients with cancer: role of inflammatory activity on iron metabolism and severity of anaemia. Med Oncol, 2007, 24: 323-329.
|
8. |
Balla J, Jeney V, Varga Z, et al. Iron homeostasis in chronic inflammation. Acta Physiol Hung, 2007, 94: 95-106.
|
9. |
Semrin G, Fishman DS, Bousvaros A, et al. Impaired intestinal iron absorption in Crohn′s disease correlates with disease activity and markers of inflammation. InflammBowel Dis, 2006, 12: 1101-1106.
|